 Research
 Open Access
 Published:
Mathematical modeling and stability analysis of macrophage activation in left ventricular remodeling postmyocardial infarction
BMC Genomics volume 13, Article number: S21 (2012)
Abstract
Background
About 6 million Americans suffer from heart failure and 70% of heart failure cases are caused by myocardial infarction (MI). Following myocardial infarction, increased cytokines induce two major types of macrophages: classically activated macrophages which contribute to extracellular matrix destruction and alternatively activated macrophages which contribute to extracellular matrix construction. Though experimental results have shown the transitions between these two types of macrophages, little is known about the dynamic progression of macrophages activation. Therefore, the objective of this study is to analyze macrophage activation patterns postMI.
Results
We have collected experimental data from adult C57 mice and built a framework to represent the regulatory relationships among cytokines and macrophages. A set of differential equations were established to characterize the regulatory relationships for macrophage activation in the left ventricle postMI based on the physical chemistry laws. We further validated the mathematical model by comparing our computational results with experimental results reported in the literature. By applying Lyaponuv stability analysis, the established mathematical model demonstrated global stability in homeostasis situation and bounded response to myocardial infarction.
Conclusions
We have established and validated a mathematical model for macrophage activation postMI. The stability analysis provided a possible strategy to intervene the balance of classically and alternatively activated macrophages in this study. The results will lay a strong foundation to understand the mechanisms of left ventricular remodelling postMI.
Background
Myocardial infarction is defined by pathology as myocytes necrosis and apoptosis due to prolonged ischemia. Since myocytes cannot divide and replace themselves, myocytes in the infarct area deprived of oxygen die and are replaced by a collagen scar. There is a series of cellular and molecular activities respond to MI in the myocardium. Myocytes apoptosis appears in the first 6 to 8 hours postMI, and necrosis occurs in 12 hrs to 4 days postMI [1]. Necrosis of myocytes results in significantly elevated interlukin1 (IL1), tumour necrotic factorβ (TNFβ), IL10, and monocyte chemotactic protein1 (MCP1) levels. MCP1 is a strong chemoattractants that recruit and confine monocytes to the injury site. It's been reported that over 95% of monocytes differentiate to macrophages [2]. There are two major types of macrophages postMI: classically activated macrophages (M1) and alternatively activated macrophages (M2). Porcheray has reported a switch between M1 and M2 macrophages with in vitro stimuli including IL4, IL10, and TNFβ [3]. In addition, biomarkers of M1 and M2 macrophages show a temporal in vivo transition [3]. Since M1 and M2 macrophages are responsible for extracellular matrix (ECM) destruction and construction, respectively, the transition and dynamic balance between two macrophage phenotypes might lead to the balance between ECM destruction and construction, and thus determine the ECM remodeling postMI.[4] Therefore, characterizing macrophage activation pattern is essential to better understand the ECM remodeling postMI.
A large amount of experimental research has been conducted to elucidate the underlying mechanisms of macrophage activation, and an abundant accumulation of experimental results define on macrophage responses to different stimuli. There is a need, however, to systemically analyze the accumulated data and integrate the results into a framework that will allow a more complete understanding. To address this need, several mathematical models have been established to characterize the effects of macrophages on wound healing, inflammatory responses, and collagen synthesis postMI [5–9]. However, most models do not consider the effect of macrophage activation patterns and ignore the differences between macrophage phenotypes. Therefore, the aim of this study was to establish and validate a set of ordinary differential equations to characterize macrophage activation patterns postMI. Since our mathematical model was established based on in vivo and in vitro experimental results, all parameters in the model were determined by the averages of the experimental data.
Results
We have collected experimental data from adult C57 mice and built a framework to represent the regulatory relationship among cytokines and macrophages. Based on this framework, we established a set of nonlinear differential equations to characterize the regulatory relationship for macrophage activation in the left ventricle postmyocardial infarction using physical chemistry laws. Our framework and the mathematical model were established based on the following three assumptions.

1)
All monocytes that migrate to the infarct region are differentiated to unactivated macrophages [10].

2)
All activated macrophages are differentiated from unactivated macrophage since previous studies have shown that <5% of macrophages undergo mitotic division [11, 12].

3)
All parameters and coefficients in this model are constant.
Framework of regulatory relationship for macrophage activation
In this framework, myocytes and monocytes were considered as inputs to the system. Cellular densities of M1 and M2 macrophages were considered as the outputs of the system. We chose IL1, IL10, and TNFα as three molecules which regulate macrophage activations in this mathematical model since they were wellrecognized as stimuli for macrophage activation [13–15]. M1 macrophages and myocytes secrete IL1 and TNFα. M2 macrophages secrete IL10 [3]. Further, TNFα and IL1 promote M1 activation and IL_10 promotes M2 activation [16]. IL10 inhibits TNFα, IL1, and itself [17]. The inputoutput and regulating relationship were shown in Figure 1.
Input to the framework
Temporal profiles of monocytes and myocytes densities were used as inputs to our mathematical framework (Figure 1). Myocytes density in healthy adult mice was 6 × 10^{9} cells/ml as an initial value. Myocytes numbers monotonically decreases postMI and is directly associated with LV wall thickness. We have measured the LV wall thickness at days 0, 1, 3, 5, and 7 postMI. The temporal profile of myocytes was determined by combining the initial value and the monotone progression trend (the crosses) as shown in Figure 2(A).
Macrophages density in the left ventricle of healthy adult mice is 2000 cells/ml, which will be used as initial values of unactivated macrophage density in this study [18, 19]. Yang et al has measured temporal profiles of macrophages postMI in mice at days 1, 2, 4, 7, 14, 21, and 28 [20]. The temporal profile of macrophages was obtained by fitting the experimental results as a continuous function as shown in Figure 2(B).
Based on our assumptions 1 and 2, all macrophages were differentiated from monocytes and emigrated from infarct area to the lymph node system. The estimation of unactivated macrophage based on the experimental results [18] is shown as follows,
where M denotes the differentiation rates of monocytes, M_{ un } denotes the unactivated macrophage density, and μ denotes the emigration rate of inactivated macrophage. Based on the temporal profile of unactivated macrophage, the monocytes differentiation rate can be estimated as shown in Figure 2(C).
Mathematical model for macrophage activation
The mathematical model of macrophage activations is a set of nonlinear differential equations represented by cellular densities (cell number/ml) of M_{ un }, M1 and M2, and concentrations (pg/ml) of chemical factors such as IL1, IL10, and TNFα. Cellular densities were determined by the difference between immigration and emigration rates. Concentrations of chemical factors were determined by the balance between their synthesis and degradation rates. The established mathematical model can be written as
where M_{ un }, M_{1}, M_{2} denote the cell densities of unactivated macrophages, M1 macrophages, and M2 macrophages, respectively. Variables IL_{10}, T_{ α }, and IL_{1} denote the concentrations of IL10, TNFα, and IL1. Variable denotes M the differentiation rate of monocytes and M_{ c } denotes the myocytes density. The parameters used in these equations with their biological meanings, experimental values, units, and references are listed in Additional file 1. All parameters were determined based on the published data or estimation from other mathematical models [3, 6, 21–28].
Equation 2 determines the density of unactivated macrophages in the infarct area. For the construction part, the unactivated macrophages are differentiated from monocytes as shown in Figure 2(C). For the destruction part, the unactivated macrophages are activated to M_{1} or M_{2}. Additionally, inactivated macrophages do not die locally in the scar tissue but die out in the lymph node system [27].
Equation 3 determines the activation rate of M1 macrophages. For the construction part, IL1 and TNFα promote M1 activation. Parameters k_{2} and k_{3} denote the activation rates of M1 macrophages by IL1 and TNFα. Hill equations are used to represent the promotion effects of IL1 and TNFα and parameters c_{IL 1}and ${c}_{{T}_{\alpha}}$ are the effectiveness of IL1 and TNFα promotion on M1 calculated based on the experimental results [3, 29]. Steinmuller has shown the transition between M1 and M2 phenotypes in vivo [21]. Correspondingly, we use parameter k_{1} to denote the transition from M1 to M2 and parameter ${k}_{1}^{\prime}$ for the transition from M2 to M1 [21]. The destruction part includes emigration of macrophage (μ)and transition from M1 to M2 macrophages (k_{1}) [27].
Equation 4 determines the activation rate of M2 macrophages. The construction part is denoted by activation of M2 macrophages promoted by IL10, and transition from M1 to M2. IL10 promotes M2 activation and this activation rate has been approximated by parameters k_{4} based on the experimental results [3]. The transition rate from M1 to M2 is denoted as k_{1}. The destruction part includes emigration of M2 macrophages (μ) and transition from M2 to M1 macrophages (${k}_{1}^{\prime}$), similarly as described in equation 3.
Equation 5 determines the secretion rate of IL10. For construction part, IL10 is secreted by M2 macrophages, and parameter k_{5} denotes the secretion rate of IL10 by M2 macrophages [22, 30]. The destruction part includes the selfinhibition and degradation of IL10. A Hill equation is employed to represent this selfinhibition effect and parameter c_{1} denotes the selfinhibition effect of IL10 postMI [6, 17]. Parameter ${d}_{I{L}_{10}}$ denotes the decay rate of IL10 determined by its halflife time [13].
Equation 6 determines the deposition rate of TNFα, which is secreted by both M1 macrophages and myocytes [6, 23, 28, 31]. We used in vitro results from Meng to determine the secretion rate of TNFα by M1 and secretion rate of TNFα by myocytes (λ) is determined by Horio's experimental results [23, 31]. The inhibition of IL10 is presented by a Hill equation where parameter c represents the effectiveness of IL10 inhibiting TNFα [25]. The destruction part is denoted by the degradation of TNFα. Parameter ${d}_{{T}_{\alpha}}$ is the decay rate of TNFα determined by its halflife time [15, 26].
Equation 7 determines the deposition rate of IL1. IL1 is secreted by both M1 macrophage and myocytes. Parameter k_{7} denotes the secretion rate of IL1 in cultured rat cardiac myocytes [31]. The inhibition of IL10 is presented by a Hill equation similarly as in equation 6 [25]. In the destruction part, parameter d_{IL 1}represents the decay rate of IL1 determined by its halflife time [14].
Stability analysis
If there is no myocardial infarction, monocytes differentiation and myocytes apoptosis should be at a very low level, and the studied macrophage activation pathway should maintain homeostasis. We have calculated the equilibrium point of the system without any input and performed Lyapunov stability analysis. Our analysis showed that without any monocytes differentiation and myocytes secretion, the system would stay at the origin when t → ∞.
In the case of myocardial infarction, myocytes apoptosis and necrosis triggered inflammatory responses and significant monocytes differentiation, which will drive the system to a new equilibrium point. Correspondingly, the cell densities of M1 and M2 increase postMI. We have obtained a steady state as E = [20, 1200, 3500, 0.73, 1.1, 5.9] from our computational simulations. The steady states match with the experimental measurements collected from healthy adults without myocardial infarction [32]. In addition, the stable region of the established mathematical model depends on the strength of the input.
Computational results
Computational simulations of macrophage activation were carried out by solving the nonlinear differential equations with MATLAB. The initial conditions of unactivated, M1 and M2 macrophage densities were chosen as M_{ un } = 2000 cells/ml and M_{1}(0) = M_{2}(0) = 0 cells/ml. The concentrations of IL1, TNFα, and IL10 were set as 0.1 pg/ml. The inputs of this system were shown in Figure 2. Outputs of the system, M1 and M2 densities, were shown in Figure 3. The concentrations of IL1, IL10 and TNFα were shown in Figure 4. Our computational results were shown as solid lines while the experimental results were shown as discrete crosses in these figures [17, 33, 34].
Our computational results demonstrated that from days 0 to day 3 postMI, cellular densities of the M1 phenotype increased at a faster rate than the M2 phenotype. At day 10, the M2 phenotype dominates over the M1 phenotype. This prediction agrees with the results reported by Troidl [4]. Additionally, temporal profiles of IL1 and TNFα significantly increased from days 0 to 1 postMI in our computational simulations, which match the experimental results reported by Sumitra [33]. Comparison between the computational and experimental results demonstrates a similar trend for the temporal profiles, suggesting the effectiveness of our model.
Discussion
This study established a mathematical model for macrophage activation in the left ventricle postMI by combining experimental and computational approaches. This is the first mathematical model focusing on the dynamic interactions among cytokines, myocytes, monocytes, and macrophages. Computational predictions based on this mathematical model match with experimental measurements, suggesting effectiveness of the model. In addition, our stability analysis provided insight for the activation pattern of macrophages postmyocardial infarction. In our mathematical model, there are two inputs, myocytes apoptosis and monocytes differentiation. In this study, we have predicted a stable equilibrium for homeostasis, which means without myocardial infarction or following small injury stimuli, macrophage densities and concentrations of IL1, IL10, and TNFα should stay at the equilibrium. After MI, the monocytes differentiated into macrophage and apoptotic myocytes secreted significant amounts of cytokines to activate the macrophages. The strength of the monocytes differentiation and myocytes apoptosis (inputs of the system) drive the system to different states while all states will be bounded due to the bounded strength of the inputs.
However, there exist some differences between computational predictions and real experimental results. To address this issue and the variation in different experiments, a stochastic parameter distribution will need to be introduced to replace the constant parameters. In addition, more detailed measurements on monocytes and myocytes and concentration temporal profiles of IL1, IL10 and TNFα from C57 mice will be carried out in our future research, which will help to solidify our equations.
Conclusions
Our study has established framework for macrophage activation and used ordinary differential equations to model the cellular interactions between macrophage activation types postMI. The results on stability analysis can be used as a useful tool to predict the behaviour of biological systems.
Methods
To incorporate the experimental data, curve fitting algorithm was applied to obtain temporal continuous density profiles of myocytes and monocytes based on discrete experimental data.
Stability analysis of the established mathematical model
To analyse the stability of the proposed mathematical model, we have calculated the equilibrium point of the system and performed the Lyapunov stability analysis of the system.
In our mathematical model, equations (27) are six firstorder equations with input M and M_{ c }. Now we use x_{1}, x_{2}, x_{3}, x_{4}, x_{5}, x_{6} to denote M_{ un }, M_{1}, M_{2}, IL_{10}, T_{ α }, IL_{1}. We first examined the stability of the system without any input and obtained an equilibrium of ${E}_{1}=\left({x}_{1}^{*},{x}_{2}^{*},{x}_{3}^{*},{x}_{4}^{*},{x}_{5}^{*},{x}_{6}^{*}\right)=\left(0,0,0,0,0,0\right)$. With the temporal input of monocytes differentiation and myocytes secretion, our computational simulation generated a steady state as ${E}_{2}=\left({x}_{1}^{*},{x}_{2}^{*},{x}_{3}^{*},{x}_{4}^{*},{x}_{5}^{*},{x}_{6}^{*}\right)=\left(20,1200,3500,0.73,1.1,5.9\right)$. To further analyze the stability property of the system, we chose a positive definite Lyapunov function
and obtained its derivative as the following equation
By applying the boundary of the Hill equations, we got
Applying the parameters in Table 1 to equation (10), we got
Since the derivative of Lyapunov function is negative semidefinite and the semidefinite is satisfied with all states equal to zero, the system is globally asymptotically stable without any input. Given any bounded differentiate rate of monocytes and myocytes density as input, the system will have bounded states.
References
 1.
Haunstetter A, Izumo S: Apoptosis: Basic Mechanisms and Implications for Cardiovascular Disease. Circ Res. 1998, 82 (11): 11111129. 10.1161/01.RES.82.11.1111.
 2.
Li Q, Park PW, Wilson CL, Parks WC: Matrilysin Shedding of Syndecan1 Regulates Chemokine Mobilization and Transepithelial Efflux of Neutrophils in Acute Lung Injury. Cell. 2002, 111 (5): 635646. 10.1016/S00928674(02)010796.
 3.
Porcheray F, Viaud S, Rimaniol AC, Léone C, Samah B, DereuddreBosquet N, Dormont D, Gras G: Macrophage activation switching: an asset for the resolution of inflammation. Clinical & Experimental Immunology. 2005, 142 (3): 481489.
 4.
Troidl C, Mollmann H, Nef H, Masseli F, Voss S, Szardien S, Willmer M, Rolf A, Rixe J, Troidl K: Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction. Journal of Cellular and Molecular Medicine. 2009, 13: 34853496. 10.1111/j.15824934.2009.00707.x.
 5.
Waugh Helen, S JA: Modeling the effects of treating diabetic wounds with engineered skin substitutes. Wound Repair and Regeneration. 2007, 15 (4): 556565. 10.1111/j.1524475X.2007.00270.x.
 6.
Day J, Friedman A, Schlesinger L: Modeling the immune rheostat of macrophages in the lung in response to infection. Proc Natl Acad Sci U S A. 2009, 106 (27): 1124611251. 10.1073/pnas.0904846106.
 7.
Vodovotz Y, Clermont G, Chow C, An G: Mathematical models of the acute inflammatory response. Curr Opin Crit Care. 2004, 10: 383390. 10.1097/01.ccx.0000139360.30327.69.
 8.
MunozAlicea RM, MarcanoVelazquez M: A mathematical model for macrophage, Tcell and mycobacterium tuberculosis interactions. 1999
 9.
Owen MR, Sherratt JA: Modelling the macrophage invasion of tumours: Effects on growth and composition. IMA J Math Appl Med Biol. 1998, 15 (2): 165185. 10.1093/imammb/15.2.165.
 10.
Krause S, Rehli M, Kreutz M, Schwarzfischer L, Paulauskis J, Andreesen R: Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol. 1996, 60: 540545.
 11.
Mantovani A: Macrophage diversity and polarization: in vivo veritas. Blood. 2006, 108 (2): 408409. 10.1182/blood200605019430.
 12.
Burke B, L C: The Macrophage. 2002, Oxford: Oxford University Press, 2
 13.
Jin Y, Lindsey M: MultiScale Modeling and Analysis of Left Ventricular Remodeling Post Myocardial Infarction: Integration of Experimental and Computational Approaches. Application of Machine Learning. 2009, 267280.
 14.
Kudo S, Mizuno K, Hirai Y, Shimizu T: Clearance and Tissue Distribution of Recombinant Human Interleukin 1α in Rats. Cancer Research. 1990, 50 (18): 57515755.
 15.
Tsutsumi Y, Kihira T, Tsunoda S, Kamada H, Nakagawa S, Kaneda Y, Kanamori T, Mayumi T: Molecular design of hybrid tumor necrosis factoralpha III: polyethylene glycolmodified tumor necrosis factoralpha has markedly enhanced antitumor potency due to longer plasma halflife and higher tumor accumulation. Journal of Pharmacology and Experimental Therapeutics. 1996, 278 (3): 1006
 16.
Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM: The dual role of IL10. Trends in Immunology. 2003, 24 (1): 3643. 10.1016/S14714906(02)000091.
 17.
Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: INTERLEUKIN10 AND THE INTERLEUKIN10 RECEPTOR. Annual Review of Immunology. 2001, 19 (1): 683765. 10.1146/annurev.immunol.19.1.683.
 18.
Jin YF, Han HC, Berger J, Dai Q, Lindsey M: Combining experimental and mathematical modeling to reveal mechanisms of macrophagedependent left ventricular remodeling. BMC Systems Biology. 2011, 5 (1): 6010.1186/17520509560.
 19.
Gao X, Xu Q, Kiriazis H, Dart A, Du X: Mouse model of postinfarct ventricular rupture: time course, strain and genderdependency, tensile strength, and histopathology. Cardiovascular Research. 2005, 65: 469477. 10.1016/j.cardiores.2004.10.014.
 20.
Yang F, Liu YH, Yang XP, Xu J, Kapke A, Carretero OA: Myocardial infarction and cardiac remodelling in mice. Exp Physiol. 2002, 87 (5): 547555. 10.1113/eph8702385.
 21.
Steinmuller C, FrankeUllmann G, LohmannMatthes ML, Emmendorffer A: Local Activation of Nonspecific Defense against a Respiratory Model Infection by Application of Interferongamma. Comparison between Rat Alveolar and Interstitial Lung Macrophages. Am J Respir Cell Mol Biol. 2000, 22 (4): 481490. 10.1165/ajrcmb.22.4.3336.
 22.
Edwards JP, Zhang X, Frauwirth KA, Mosser DM: Biochemical and functional characterization of three activated macrophage populations. Journal of Leukocyte Biology. 2006, 80: 12981307. 10.1189/jlb.0406249.
 23.
Meng F, Lowell CA: Lipopolysaccharide (LPS)induced Macrophage Activation and Signal Transduction in the Absence of SrcFamily Kinases Hck, Fgr, and Lyn. The Journal of Experimental Medicine. 1997, 185 (9): 16611670. 10.1084/jem.185.9.1661.
 24.
Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology. 2004, 25 (12): 677686. 10.1016/j.it.2004.09.015.
 25.
Marino S, Hogue IB, Ray CJ, Kirschner DE: A methodology for performing global uncertainty and sensitivity analysis in systems biology. Journal of theoretical biology. 2008, 254 (1): 178196. 10.1016/j.jtbi.2008.04.011.
 26.
Oliver J, Bland L, Oettinger C, Arduino M, McAllister S, Aguero S, Favero M: Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge. Lymphokine and cytokine research. 1993, 12 (2): 115
 27.
Rohde L, Ducharme A, Arroyo L, Aikawa M, Sukhova G, LopezAnaya A, McClure K, Mitchell P, Libby P, Lee R: Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation. 1999, 99: 30633070. 10.1161/01.CIR.99.23.3063.
 28.
Maass DL, Hybki DP, White J, Horton JW: The Time Course of Cardiac NF[kappa]B Activation and TNF[alpha] Secretion by Cardiac Myocytes After Burn Injury: Contribution to BurnRelated Cardiac Contractile Dysfunction. Shock. 2002, 17 (4): 293299. 10.1097/0002438220020400000009.
 29.
Onozaki K, Urawa H, Tamatani T, Iwamura Y, Hashimoto T, Baba T, Suzuki H, Yamada M, Yamamoto S, Oppenheim J: Synergistic interactions of interleukin 1, interferonbeta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferonbeta is an autocrine differentiating factor. The Journal of Immunology. 1988, 140 (1): 112119.
 30.
Edwards JP, Zhang X, Frauwirth KA, Mosser DM: Biochemical and functional characterization of three activated macrophage populations. Journal of Leukocyte Biology. 2006, 80 (6): 12981307. 10.1189/jlb.0406249.
 31.
Horio T, Nishikimi T, Yoshihara F, Nagaya N, Matsuo H, Takishita S, Kangawa K: Production and Secretion of Adrenomedullin in Cultured Rat Cardiac Myocytes and Nonmyocytes: Stimulation by Interleukin1α and Tumor Necrosis Factorα. Endocrinology. 1998, 139 (11): 45764580. 10.1210/en.139.11.4576.
 32.
Steensberg A, Fischer CP, Keller C, Møller K, Pedersen BK: IL6 enhances plasma IL1ra, IL10, and cortisol in humans. American Journal of Physiology  Endocrinology And Metabolism. 2003, 285 (2): E433E437.
 33.
Sumitra M, Manikandan P, Nayeem M, Manohar B, Lokanadam B, Vairamuthu S, Subramaniam S, Puvanakrishnan R: Time course studies on the initiation of complement activation in acute myocardial infarction induced by coronary artery ligation in rats. Molecular and cellular biochemistry. 2005, 268: 149158. 10.1007/s1101000538568.
 34.
Frangogiannis NG, Mendoza LH, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML: IL10 Is Induced in the Reperfused Myocardium and May Modulate the Reaction to Injury. The Journal of Immunology. 2000, 165 (5): 27982808.
 35.
Yang F, Liu Y, Yang X, Xu J, Kapke A, Carretero O: Myocardial infarction and cardiac remodelling in mice. Experimental Physiology. 2002, 87 (5): 547555. 10.1113/eph8702385.
 36.
Patti G, D'Ambrosio A, Mega S, Giorgi G, Zardi EM, Zardi DM, Dicuonzo G, Dobrina A, Di Sciascio G: Early interleukin1 receptor antagonist elevation in patients with acute myocardial infarction. Journal of the American College of Cardiology. 2004, 43 (1): 3538. 10.1016/j.jacc.2003.07.032.
 37.
Drimal J, Knezl V, Paulovicova E, Drimal D: Enhanced early aftermyocardial infarction concentration of TNFalpha subsequently increased circulating and myocardial adrenomedullin in spontaneously hypertensive rats. General physiology and biophysics. 2008, 27 (1): 12
 38.
Wang Y, Jin Y, Ma Y, Halade GV, Linsey ML: Mathematical modeling of macrophage activation in left ventricular remodeling postmyocardial infarction. Genomic Signal Processing and Statistics (GENSIPS), 2011 IEEE International Workshop on: 46 December 2011. 2011, 202205. 10.1109/GENSiPS.2011.6169480.
Acknowledgements
Based on “Mathematical modeling of macrophage activation in left ventricular remodeling postmyocardial infarction”, by Yunji Wang, YuFang Jin, Yonggang Ma, Ganesh V Halade and Merry L Linsey which appeared in Genomic Signal Processing and Statistics (GENSIPS), 2011 IEEE International Workshop on. © 2011 IEEE [38].
The authors acknowledge grant and contract support from NHLBI HHSN268201000036C (N01HV00244), NIH R01 HL75360, Veteran's Administration Merit Award, and the Max and Minnie Tomerlin Voelcker Fund (to M.L.L.), and NIH 1R03EB009496, and NIH SC2HL101430 (to Y.F.J.).
This article has been published as part of BMC Genomics Volume 13 Supplement 6, 2012: Selected articles from the IEEE International Workshop on Genomic Signal Processing and Statistics (GENSIPS) 2011. The full contents of the supplement are available online at http://www.biomedcentral.com/bmcgenomics/supplements/13/S6.
Author information
Affiliations
Corresponding author
Additional information
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
Y.F.J and M.L.L designed the research; Y.F.J and Y.W performed the computational analysis and simulation. Y.F.J, Y.W, T.Y, Y.M, G.V.H, M.Z, and M.L.L analyzed the results and wrote the manuscript.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Wang, Y., Yang, T., Ma, Y. et al. Mathematical modeling and stability analysis of macrophage activation in left ventricular remodeling postmyocardial infarction. BMC Genomics 13, S21 (2012). https://doi.org/10.1186/1471216413S6S21
Published:
Keywords
 Macrophage Activation
 Destruction Part
 Myocytes Apoptosis
 Monocyte Differentiation
 Macrophage Density